FEB 25, 2025
Integrated Nanotherapeutics will be attending the 8th Antigen-Specific Immune Tolerance Drug Development Summit (ASIT) 2025, Feb 25 – 27, in Boston.
JAN 13, 2025
Integrated Nanotherapeutics will be attending Biotech Showcase 2025 during JPM Week, Jan 13 – 15, in San Francisco.
SEP 09, 2024
Integrated Nanotherapeutics and Breakthrough T1D Collaborate to Advance Development of an Immune Tolerizing Therapeutic to Treat Type 1 Diabetes.
JUN 11, 2024
Integrated Nanotherapeutics is presenting T1D preclinical data at the Federation of Clinical Immunology Societies (FOCIS) 2024 Annual Meeting, June 18 – 21, in San Francisco.